Thyroid Gland Oncocytic Neoplasm — knowledge graph · CancerIndex

Knowledge graph · Cancer

Thyroid Gland Oncocytic Neoplasm

subtype

Identifier: CI-CAN-00004126
Entity page: /cancer/thyroid-gland-oncocytic-neoplasm ↗
Edges: 27

Neighbours: 14 drugs10 trials
Drawn: 24 of 24 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Thyroid Gland Oncocytic Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived14 of 14
→ investigated in trials for	Cabozantinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Thyroid Gland Oncocytic Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cediranibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants

Thyroid Gland Oncocytic Neoplasm studied in …STUDIED_INderived10 of 13show all (up to 200)
→ studied in	NCT04544111Phase 2 · active not recruiting PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer · condition mapped ALIAS · 13 trials mapped (6 active)	—	—	Thyroid Gland Oncocytic Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT00001160recruiting Studies on Tumors of the Thyroid · condition mapped ALIAS · 13 trials mapped (6 active)	—	—	Thyroid Gland Oncocytic Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05453799Phase 2 · suspended Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer · condition mapped CURATED_BROADER · 13 trials mapped (6 active)	—	—	Thyroid Gland Oncocytic Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03914300Phase 2 · active not recruiting Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Thyroid Gland Oncocytic Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06959641Phase 2 · recruiting XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer · condition mapped CURATED_BROADER · 13 trials mapped (6 active)	—	—	Thyroid Gland Oncocytic Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02143726Phase 2 · active not recruiting Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer · condition mapped CURATED_BROADER · 13 trials mapped (6 active)	—	—	Thyroid Gland Oncocytic Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06440850Phase 2 · recruiting Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Thyroid Gland Oncocytic Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02973997Phase 2 · completed Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) · condition mapped ALIAS · 13 trials mapped (6 active)	—	—	Thyroid Gland Oncocytic Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05410821Phase 1 · completed Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer · condition mapped CURATED_BROADER · 13 trials mapped (6 active)	—	—	Thyroid Gland Oncocytic Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00381641Phase 2 · completed Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Thyroid Gland Oncocytic Carcinoma	1	Observed	clinicaltrials	graph →